Dan S. Kaufman

Dan Kaufman is a leader in developing induced pluripotent stem cell (iPSC)-derived natural killer cells for cancer immunotherapy. His laboratory has established robust methods for differentiating iPSCs into functional NK cells that can be genetically engineered with CARs and other enhancements. This approach enables unlimited production of standardized NK cell products for off-the-shelf cancer therapy.

Dan Kaufman是开发诱导多能干细胞（iPSC）衍生的自然杀伤细胞用于癌症免疫治疗的领导者。他的实验室建立了将iPSC分化为功能性NK细胞的稳健方法，这些细胞可以通过CAR和其他增强进行基因工程改造。这种方法能够无限生产标准化的NK细胞产品用于现成的癌症治疗。